About this study.
CMV is a common virus, and most people never have symptoms of CMV. However, CMV can cause health problems for some babies whose mothers become infected with CMV during pregnancy. This study is intended to test the safety and effectiveness of a potential immunization designed to protect you from getting the CMV virus. Healthy women from 16 to 35 years of age who regularly spend time with young children are invited to see if they qualify.
Those who qualify for this study will receive:
$50 per office visit (including $50 at screening visit), and $25 for monthly self-collected saliva sample and urine sample. Participants can make up to $1,300.
About Cytomegalovirus (CMV)CMV is a virus in the same family as the herpes virus that is present in a large portion of the population. CMV is spread by direct contact with body fluids, such as saliva, blood, urine, tears, etc.Most CMV infections are “silent,” meaning most people who are infected with CMV exhibit no signs or symptoms. However, CMV can cause serious disease in newborns when a mother is infected during pregnancy – this is known as congenital CMV infection. CMV is the leading cause of non-genetic childhood hearing loss. It is estimated that every hour, one child is permanently disabled by CMV, and scientific research has found a connection between CMV and miscarriage.
People choose to participate for a variety of reasons. Perhaps they don’t have access to quality medical care, or they are looking to help others by contributing to medical research. Some people are out of options and just hoping to find something that works. It doesn’t matter why they chose to participate; they are the champions who are helping to develop new treatments for the future.